KLP Kapitalforvaltning’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$43M Hold
199,177
0.14% 127
2026
Q1
$36.5M Buy
199,177
+7,500
+4% +$1.38M 0.14% 140
2025
Q4
$33.7M Buy
191,677
+25,100
+15% +$4.1M 0.13% 142
2025
Q3
$23.3M Hold
166,577
0.09% 209
2025
Q2
$20.9M Buy
166,577
+10,500
+7% +$1.31M 0.09% 221
2025
Q1
$21.4M Buy
156,077
+63,700
+69% +$9.11M 0.1% 202
2024
Q4
$14.1M Buy
+92,377
New +$15.6M 0.07% 280

Other funds holding BIIB

KLP Kapitalforvaltning's BIIB Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Biogen (BIIB) position steady in Q2 2026 at 199,177 shares worth $43M. The position accounts for 0.14% of the portfolio, ranked #127.

KLP Kapitalforvaltning first reported a position in BIIB in Q4 2024 and has held it in 7 quarters since. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • KLP Kapitalforvaltning held 199,177 shares of Biogen worth $43M as of Q2 2026.
  • KLP Kapitalforvaltning left its Biogen share count unchanged in Q2 2026.
  • Biogen made up 0.14% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #127 holding.
  • KLP Kapitalforvaltning first reported a position in Biogen in Q4 2024 and has held it in 7 quarters since.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.